Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Explore Which Performs Better Total Return Vs Price Index and understand the circumstances under which each metric shines for investors.
27,082 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
In a choppy 2026 market, a momentum-focused ETF is gaining attention for its track record of catching leaders while a...
A major capital shift is unfolding as chipmakers gain ground while hyperscalers slow. NVIDIA and Micron are set to be...
A Roth IRA can dramatically boost after-tax income from dividend stocks that generate steady cash flow. This report b...
Alphabet shifted gears, stepping away from a $346B AI bet to chase faster AI-driven wins. Here’s what that means for ...
Rising Treasury yields are lifting single premium immediate annuities, offering guaranteed lifetime income for retire...
Enterprise Products Partners closed 2025 with record cash flow and a steady ~6% yield, extending a 26-year payout str...
Scotiabank announces the acquisition of Maple Financial Holdings, owner of MapleMark Bank, to bolster its U.S. mortga...
A soon-to-retire investor outlines a simple, income-centric ETF strategy built around three funds—JEPQ, DIVO, and SPH...
A veteran economist warns that the long-standing cushion for markets is thinning. AI-driven gains mask growing vulner...
Gold climbs to new highs in March 2026 as a 2x gold ETF accelerates gains. With real yields sliding, leveraged exposu...
Investors are buzzing about Revolution Medicines this year as its RAS-focused cancer programs advance. This article l...